Unbound MEDLINE

Additional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples. AIDS (London, England) [AIDS] Journal article

 
TitleAdditional HIV-1 mutation patterns associated with reduced phenotypic susceptibility to etravirine in clinical samples.
Author(s)Kagan RM, Sista P, Pattery T, Bacheler L, Schwab DA 
InstitutionaDepartment of Infectious Diseases, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, USA bVircoLab Inc., Durham, North Carolina, USA cVirco BVBA, Mechelen, Belgium.
SourceAIDS 2009 May 25.
AbstractWe investigated the phenotypic impact of a number of uncommon amino acid substitutions at HIV-1 reverse transcriptase positions 103 and 138, which are not part of the etravirine resistance score and were found in combination with the high-impact mutation K101P. Etravirine phenotypic fold changes were 380-1400 for K101P + E138A/G/Q + K103N/S/T + V179I and 12-130 for K101P + (K103S +/- V179I) in the absence of E138A/G/Q. Although the effect of K103S is unclear, additional position 138 substitutions seem important for etravirine susceptibility.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19474648
  
Advertise on this site.